Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis: association with dominant amyloid-related organ involvement and survival after stem cell transplantation

被引:67
作者
Comenzo, RL
Wally, J
Kica, G
Murray, J
Ericsson, T
Skinner, M
Zhang, YN
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Div Hematol Oncol, New York, NY 10021 USA
[2] Boston Med Ctr, Hematol Oncol Sect, Boston, MA USA
[3] Boston Med Ctr, Sect Arthrit, Dept Med, Boston, MA USA
关键词
AL amyloidosis; immunoglobulin genes; plasma cells; stem cell transplantation; immunoglobulin light chains;
D O I
10.1046/j.1365-2141.1999.01591.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AL (primary or immunoglobulin light chain) amyloidosis (AL) differs from myeloma per se in that tissue deposits of amyloid are found, typically in association with smalt numbers of clonal plasma cells producing lambda light chains, and also in that AL patients typically present with a predominantly dysfunctional organ-system This constellation of features - fibrillar deposits comprised of light chains, lambda light chain predominance, and organ-system tropism and dysfunction - remains unexplained. Select patients with AL respond to haemopoietic stem cell transplantation (SCT) with clinical improvement and extended survival. particularly those who do not have cardiac involvement. In order to ascertain whether the organ-system tropism of AL was associated with immunogloblin light chain variable region (Ig V-L) germline gene utilization, we attempted to clone, sequence and assign germline donors to the clonal Ig V-L genes of 62 AL patients, all of whom were treated with SCT. We succeeded in 39 cases, identifying clonal AL genes derived from donors of the lambda I (n=10), lambda II (n = 5), lambda III (n = 6), lambda VI (n = 11) and KI (n = 7) subtypes. The majority of the donors (IGLV6S1, DPL5, DPL2, DPL23 and LFVK431) were genes that appear in the expressed repertoire <5% of the time, suggesting an intrinsic propensity to form amyloid under certain conditions. Patients whose clones derived from the lambda VI IGLV6S1 donor uniformly presented with dominant renal involvement while those with other V-lambda or unknown donors often had dominant cardiac or other organ involvement, particularly patients whose clones derived from the XI DPL2 donor. In addition, both early (<3 months) and overall post-SCT survival were significantly better in lambda VI IGLV6S1 patients compared to patients with other V-lambda donors. These findings indicate that there are important associations in AL amyloidosis among Ig V-L gene utilization, organ-system tropism and post-SCT survival.
引用
收藏
页码:744 / 751
页数:8
相关论文
共 38 条
  • [1] BASIC LOCAL ALIGNMENT SEARCH TOOL
    ALTSCHUL, SF
    GISH, W
    MILLER, W
    MYERS, EW
    LIPMAN, DJ
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) : 403 - 410
  • [2] Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin
    Aprile, C
    Marinone, G
    Saponaro, R
    Bonino, C
    Merlini, G
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1995, 22 (12): : 1393 - 1401
  • [3] BAKKUS MHC, 1992, BLOOD, V80, P2326
  • [4] BAST EJEG, 1982, CLIN EXP IMMUNOL, V47, P677
  • [5] THE BONE-MARROW OF MULTIPLE-MYELOMA PATIENTS CONTAINS B-CELL POPULATIONS AT DIFFERENT STAGES OF DIFFERENTIATION THAT ARE CLONALLY RELATED TO THE MALIGNANT PLASMA-CELL
    BILLADEAU, D
    AHMANN, G
    GREIPP, P
    VANNESS, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) : 1023 - 1031
  • [6] MECHANISMS OF DISEASE - MONOCLONAL IMMUNOGLOBULIN DEPOSITION - AMYLOIDOSIS, LIGHT CHAIN DEPOSITION DISEASE, AND LIGHT AND HEAVY-CHAIN DEPOSITION DISEASE
    BUXBAUM, J
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) : 323 - 346
  • [7] Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis
    Comenzo, RL
    Sanchorawala, V
    Fisher, C
    Akpek, G
    Farhat, M
    Cerda, S
    Berk, JL
    Dember, LM
    Falk, R
    Finn, K
    Skinner, M
    Vosburgh, E
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (03) : 553 - 559
  • [8] Mobilized CD34+ cells selected as autografts in patients with primary light-chain amyloidosis: rationale and application
    Comenzo, RL
    Michelle, D
    LeBlanc, M
    Wally, J
    Zhang, Y
    Kica, G
    Karandish, S
    Arkin, CF
    Wright, DG
    Skinner, M
    McMannis, J
    [J]. TRANSFUSION, 1998, 38 (01) : 60 - 69
  • [9] Comenzo RL, 1998, BLOOD, V91, P3662
  • [10] COMENZO RL, 1999, HEMATOPOIETIC CELL T, P1014